Market Place
Sourcing Support
PassPort Tech Announces Positive Results of Zolmitriptan for the Treatment of AM
29 Mar 2024 //
PR NEWSWIRE
PassPort Initiated Ph I Trial of Zolmitriptan Transdermal Microporation System
23 Feb 2024 //
PR NEWSWIRE
Migraine patch developer Zosano Pharma suspends program
04 May 2022 //
BIZJOURNALS
FDA Rejects Zosano`s Application For Zolmitriptan Microneedle System Again
22 Feb 2022 //
BENZINGA
Padagis Announces The First-to-Market Launch Of An AB Rated Generic Zomig
16 Nov 2021 //
PRNEWSWIRE
Padagis Launches AB Rated Generic Version Of Zomig Nasal Spray
16 Nov 2021 //
PRNEWSWIRE
Zosano evaluates C213 in Phase II/III cluster headache trial
25 Oct 2019 //
CLINICALTRIALSARENA
Zosano Pharma Initiates Phase 2/3 Clinical Study in Second Late Stage Program
24 Oct 2019 //
BIOSPACE
Zosano launches Phase 2/3 study of zolmitriptan for cluster headache
24 Oct 2019 //
SEEKINGALPHA
Orchid Hlthcare’S Generic Zolmitriptan Receives Approval In US
23 Oct 2019 //
FDA
AstraZeneca sells 3 drugs for $350M upfront
11 Mar 2019 //
BIOPHARMADIVE
Zosano Pharma Enters Lease Agreement With Trinity Capital
26 Sep 2018 //
GLOBENEWSWIRE
Amneal Announces Favorable Ruling Regarding Patent Validity for Zomig®
29 Jun 2018 //
PR NEWSWIRE
Appco Pharma’s Generic Zolmitriptan Receives Approval In US
04 Jul 2017 //
FDA
AZ divests migraine drug to Grunenthal
08 Jun 2017 //
PHARMA TIMES
Impax Announces Favorable Ruling Regarding Patent Validity for Zomig Nasal Spray
31 Mar 2017 //
PR NEWSWIRE
PLD Acquisitions Generic Zolmitriptan Receives Approval In US
01 Mar 2017 //
FDA
Alembic Pharma gets US FDA nod for anti-migraine drug
05 Dec 2016 //
ECONOMIC TIMES
Alembic`s Generic Zolmitriptan Receives Approval In US
01 Dec 2016 //
FDA
Ajanta Pharma gets USFDA nod for migraine pain relief drug
23 May 2016 //
ECONOMIC TIMES
USFDA Approves Aurobindo’s ANDA for Zomig
16 May 2016 //
TWOFOUR INSIGHT
Macleods` Generic Zolmitriptan (2.5mg) approved in US for Migraines
01 Oct 2015 //
FDA
Alembic Pharms` Generic Zolmitriptan approved in US for Migraines
30 Sep 2015 //
FDA
Impax Laboratories Expects More M A After Latest Deal Closes
14 Jan 2015 //
THE STREET
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.